IN2015DN02999A - - Google Patents
Info
- Publication number
- IN2015DN02999A IN2015DN02999A IN2999DEN2015A IN2015DN02999A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A IN 2999DEN2015 A IN2999DEN2015 A IN 2999DEN2015A IN 2015DN02999 A IN2015DN02999 A IN 2015DN02999A
- Authority
- IN
- India
- Prior art keywords
- field
- relates
- medicine
- glucocorticoids
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
The invention relates to the field of medicine, in particular to the field of veterinary medicine. The invention relates to a pharmaceutical (medicament) formulation of glucocorticoids, especially ciclesonide or a pharmaceutically acceptable derivative thereof.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12199302 | 2012-12-21 | ||
EP13190393 | 2013-10-25 | ||
PCT/EP2013/077266 WO2014096116A1 (en) | 2012-12-21 | 2013-12-18 | Pharmaceutical formulation comprising ciclesonide |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2015DN02999A true IN2015DN02999A (en) | 2015-09-25 |
Family
ID=49779929
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2999DEN2015 IN2015DN02999A (en) | 2012-12-21 | 2013-12-18 |
Country Status (10)
Country | Link |
---|---|
US (3) | US10925964B2 (en) |
EP (2) | EP3473255B1 (en) |
AU (1) | AU2013360692B2 (en) |
CA (1) | CA2888431C (en) |
DK (2) | DK3473255T3 (en) |
ES (2) | ES2909039T3 (en) |
IN (1) | IN2015DN02999A (en) |
LT (2) | LT2934544T (en) |
MX (1) | MX364652B (en) |
WO (1) | WO2014096116A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ706573A (en) | 2012-12-21 | 2019-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
LT2934544T (en) | 2012-12-21 | 2019-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical formulation comprising ciclesonide |
KR102618119B1 (en) * | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
PL3464318T3 (en) | 2016-06-02 | 2021-11-08 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
US10772970B2 (en) | 2017-12-01 | 2020-09-15 | Abbvie Inc. | Glucocorticoid receptor agonist and immunoconjugates thereof |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5954049A (en) * | 1991-10-15 | 1999-09-21 | Trudell Medical Limited | Equine mask with MDI adapter |
DE19536902A1 (en) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Miniature fluid pressure generating device |
US5823179A (en) | 1996-02-13 | 1998-10-20 | 1263152 Ontario Inc. | Nebulizer apparatus and method |
US6264923B1 (en) | 1998-05-13 | 2001-07-24 | 3M Innovative Properties Company | Medicinal aerosol formulation of ciclesonide and related compounds |
DE10050994A1 (en) | 2000-10-14 | 2002-04-18 | Boehringer Ingelheim Pharma | New diphenylalkanoic acid azabicyclooctane ester quaternary salts useful as anticholinergic agents, especially in treatment of asthma and chronic obstructive pulmonary disease |
US6706726B2 (en) | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
DE10062712A1 (en) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | New drug compositions based on anticholinergics and corticosteroids |
US6904908B2 (en) | 2002-05-21 | 2005-06-14 | Trudell Medical International | Visual indicator for an aerosol medication delivery apparatus and system |
US7244742B2 (en) | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
DE10237739A1 (en) | 2002-08-17 | 2004-02-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhalable medicament for treating inflammatory or obstructive respiratory diseases, containing synergistic combination of tropane derivative anticholinergic agent, corticosteroid and beta-mimetic agent |
WO2004023984A2 (en) | 2002-09-13 | 2004-03-25 | Smith C Steven | Novel composition and method for treatment of upper respiratory conditions |
CA2525943A1 (en) * | 2003-05-22 | 2004-12-02 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
CA2538419C (en) * | 2003-09-16 | 2012-07-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases |
PE20050941A1 (en) | 2003-12-16 | 2005-11-08 | Nycomed Gmbh | AQUEOUS CYCLESOUND SUSPENSIONS FOR MISTING |
WO2005102354A1 (en) | 2004-04-20 | 2005-11-03 | Altana Pharma Ag | Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
EP1763344A1 (en) * | 2004-06-29 | 2007-03-21 | Boehringer Ingelheim International GmbH | Medicaments for inhalation comprising steroids and an anticholinergic |
DE102004056579A1 (en) | 2004-11-23 | 2006-05-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Inhaled drugs containing a new anticholinergic, salmeterol and a steroid |
UY30543A1 (en) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS |
UY30542A1 (en) * | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | AEROSOL FORMULATION FOR INHALATION OF BETA AGONISTS |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
US9084660B2 (en) | 2009-06-25 | 2015-07-21 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
US20150202297A1 (en) | 2012-07-05 | 2015-07-23 | Arven Ilac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose and a ternary component |
US20150202148A1 (en) | 2012-07-05 | 2015-07-23 | Arven llac Sanayi Ve Ticaret Anonim Sirketi | Dry powder inhalers comprising a carrier other than lactose |
US9539408B2 (en) | 2012-10-31 | 2017-01-10 | Trudell Medical International | Nebulizer apparatus |
LT2934544T (en) | 2012-12-21 | 2019-02-25 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical formulation comprising ciclesonide |
NZ706573A (en) | 2012-12-21 | 2019-11-29 | Boehringer Ingelheim Vetmedica Gmbh | Ciclesonide for the treatment of airway disease in horses |
CA2913811C (en) | 2013-08-20 | 2022-06-07 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
CA3129707C (en) | 2013-08-20 | 2023-04-25 | Boehringer Ingelheim Vetmedica Gmbh | Inhaler |
KR102618119B1 (en) | 2014-06-18 | 2023-12-27 | 베링거잉겔하임베트메디카게엠베하 | Muscarinic antagonists and combinations thereof for the treatment of airway disease in horses |
-
2013
- 2013-12-18 LT LTEP13808056.9T patent/LT2934544T/en unknown
- 2013-12-18 US US14/132,578 patent/US10925964B2/en active Active
- 2013-12-18 AU AU2013360692A patent/AU2013360692B2/en active Active
- 2013-12-18 LT LTEP18204242.4T patent/LT3473255T/en unknown
- 2013-12-18 ES ES18204242T patent/ES2909039T3/en active Active
- 2013-12-18 EP EP18204242.4A patent/EP3473255B1/en active Active
- 2013-12-18 WO PCT/EP2013/077266 patent/WO2014096116A1/en active Application Filing
- 2013-12-18 EP EP13808056.9A patent/EP2934544B1/en active Active
- 2013-12-18 CA CA2888431A patent/CA2888431C/en active Active
- 2013-12-18 MX MX2015007731A patent/MX364652B/en active IP Right Grant
- 2013-12-18 DK DK18204242.4T patent/DK3473255T3/en active
- 2013-12-18 ES ES13808056T patent/ES2706757T3/en active Active
- 2013-12-18 IN IN2999DEN2015 patent/IN2015DN02999A/en unknown
- 2013-12-18 DK DK13808056.9T patent/DK2934544T3/en active
-
2020
- 2020-12-23 US US17/132,038 patent/US11819549B2/en active Active
-
2023
- 2023-10-05 US US18/481,566 patent/US20240024482A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
LT2934544T (en) | 2019-02-25 |
DK2934544T3 (en) | 2019-03-04 |
DK3473255T3 (en) | 2022-04-04 |
EP2934544B1 (en) | 2018-11-07 |
LT3473255T (en) | 2022-03-10 |
US20210106685A1 (en) | 2021-04-15 |
US20240024482A1 (en) | 2024-01-25 |
WO2014096116A1 (en) | 2014-06-26 |
CA2888431C (en) | 2021-10-19 |
CA2888431A1 (en) | 2014-06-26 |
AU2013360692A1 (en) | 2015-04-23 |
MX364652B (en) | 2019-05-03 |
US11819549B2 (en) | 2023-11-21 |
MX2015007731A (en) | 2015-09-07 |
ES2706757T3 (en) | 2019-04-01 |
US10925964B2 (en) | 2021-02-23 |
EP3473255B1 (en) | 2022-01-12 |
ES2909039T3 (en) | 2022-05-05 |
AU2013360692B2 (en) | 2018-08-09 |
US20140179650A1 (en) | 2014-06-26 |
EP2934544A1 (en) | 2015-10-28 |
EP3473255A1 (en) | 2019-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2015000278A1 (en) | Autotaxin inhibitors | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
PH12016500094A1 (en) | Autotaxin inhibitors | |
MX2016016666A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
MX2016015093A (en) | Boronic acid derivatives and therapeutic uses thereof. | |
PH12015502002B1 (en) | Tripeptide epoxy ketone protease inhibitors | |
MX2014009757A (en) | Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy. | |
PH12015500713B1 (en) | Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases | |
EP2849770A4 (en) | Pharmaceutical compositions for the delivery of substantially water-insoluble drugs | |
IN2015DN03984A (en) | ||
EP4360621A3 (en) | Formulations of bendamustine | |
MY165888A (en) | Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation | |
JO3326B1 (en) | Tripeptide Epoxy Ketone Protease Inhibitors | |
HK1211021A1 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions 2--6--9--9h- | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
IN2015DN02999A (en) | ||
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2016006544A (en) | Withanolides useful for the treatment of neurodegenerative diseases. | |
IN2013CH04314A (en) | ||
MX2013003022A (en) | Pharmaceutical compositions of montelukast and levocetirizine. | |
UA74882U (en) | Pharmaceutical composition for treatment of sexual dysfunction | |
RU2011145777A (en) | MEDICINAL PREPARATION FOR ANTI-INFLAMMATORY ANTI-INFLAMMATORY ACTIVITY |